Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
mBio ; 13(3): e0018122, 2022 06 28.
Artigo em Inglês | MEDLINE | ID: covidwho-1816698

RESUMO

Understanding immune memory to COVID-19 vaccines is critical for the design and optimal vaccination schedule for curbing the COVID-19 pandemic. Here, we assessed the status of humoral and cellular immune responses at 1, 3, 6, and 12 months after two-dose CoronaVac vaccination. A total of 150 participants were enrolled, and 136 of them completed the study through the 12-month endpoint. Our results show that, at 1 month after vaccination, both binding and neutralizing antibodies could be detected; the seropositive rate of binding antibodies and seroconversion rate of neutralizing antibodies were 99% and 50%, respectively. From 3 to 12 months, the binding and neutralizing antibodies declined over time. At 12 months, the binding and neutralizing antibodies were still detectable and significantly higher than the baseline. Gamma interferon (IFN-γ) and interleukin 2 (IL-2) secretion specifically induced by the receptor-binding domain (RBD) persisted at high levels until 6 months and could be observed at 12 months, while the levels of IL-5 and granzyme B (GzmB) were hardly detected, demonstrating a Th1-biased response. In addition, specific CD4+ T central memory (TCM), CD4+ effector memory (TEM), CD8+ TEM, and CD8+ terminal effector (TE) cells were all detectable and functional up to 12 months after the second dose, as the cells produced IFN-γ, IL-2, and GzmB in response to stimulation of SARS-CoV-2 RBD. Our work provides evidence that CoronaVac induced not only detectable binding and neutralizing antibody responses, but also functional SARS-CoV-2-specific CD4+ and CD8+ memory T cells for up to 12 months. IMPORTANCE CoronaVac is an inactivated vaccine containing whole-virion SARS-CoV-2, which has been approved in 43 countries for emergency use as of 26 November 2021. However, the long-term immune persistence of the CoronaVac vaccine is still unknown. Here, we reported the status of the persistence of antibodies and cellular responses within 12 months after two doses of CoronaVac. Such data are crucial to inform ongoing and future vaccination strategies to combat COVID-19.


Assuntos
Vacinas contra COVID-19 , COVID-19 , Imunidade Celular , Imunidade Humoral , Vacinas de Produtos Inativados , Anticorpos Neutralizantes , Anticorpos Antivirais , Linfócitos T CD8-Positivos , COVID-19/prevenção & controle , Vacinas contra COVID-19/imunologia , Humanos , Interleucina-2 , Pandemias , SARS-CoV-2 , Vacinação , Vacinas de Produtos Inativados/imunologia
2.
Int J Infect Dis ; 117: 97-102, 2022 Apr.
Artigo em Inglês | MEDLINE | ID: covidwho-1699545

RESUMO

OBJECTIVES: To determine the status of immune responses after primary and booster immunization for SARS-CoV-2 variants and evaluate the differences in disease resistance based upon titers of neutralizing antibodies (NAbs) against the variants. METHODS: Participants aged 18-59 years received 2 doses of inactivated COVID-19 vaccine, 14 days apart, and a booster dose after 12 months. Blood samples were collected before vaccination (baseline), 1 and 6 months after primary immunization, and at multiple instances within 21 days of the booster dose. NAbs against the spike protein of Wuhan-Hu-1 and 3 variants were measured using pseudovirus neutralization assays. RESULTS: Of 400 enrolled participants, 387 completed visits scheduled within 6 months of the second dose and 346 participants received the booster dose in the follow-up research. After 1 month of primary immunization, geometric mean titers (GMTs) of NAbs peaked for Wuhan-Hu-1, whereas GMTs of other variants were <30. After 6 months of primary immunization, GMTs of NAbs against all strains were <30. After 3 days of booster immunization, GMTs were unaltered, seroconversion rates reached approximately 50% after 7 days, and GMTs of NAbs against all strains peaked at 14 days. CONCLUSION: Two-dose of inactivated COVID-19 vaccine induced the formation of NAbs and memory-associated immune responses, and high titers of NAbs against the variants obtained after booster immunization may further improve the effectiveness of the vaccine.


Assuntos
COVID-19 , SARS-CoV-2 , Adolescente , Adulto , Anticorpos Neutralizantes , Anticorpos Antivirais , COVID-19/prevenção & controle , Vacinas contra COVID-19 , Humanos , Imunização Secundária , Pessoa de Meia-Idade , Adulto Jovem
3.
Vaccine ; 40(7): 994-1000, 2022 02 11.
Artigo em Inglês | MEDLINE | ID: covidwho-1627730

RESUMO

BACKGROUND: Since 2007, Beijing has offered a free trivalent influenza vaccine (TIV) for residents aged ≥ 60 years and school students. The quadrivalent influenza vaccine (QIV) was administered to school children in 2018 and will be administered to elderly adults in the future. In addition, health care workers (HCWs) who are involved in the prevention and control of COVID-19 were included in the program in 2020. This study aimed to analyze the cost-effectiveness of a comprehensive list of combined strategies of TIV and QIV for school children, elderly adults, and HCWs to identify the most cost-effective strategy. METHODS: A decision tree was developed to compare 1-year outcomes of TIV vs. QIV in three risk groups: school children, elderly adults, and HCWs. The outcome was incremental cost per quality-adjusted life-year (QALY). Probabilistic sensitivity analyses and scenario analyses were developed to assess the robustness of the results. RESULTS: From the perspective of society, this study found that the introduction of QIVs can be cost-effective for any and all targeted groups with a willingness-to-pay threshold of 3-fold GDP per capita. Among all programs, program H (all school children, elderly adults, and HCWs received the QIV) showed a 79% probability of being cost-effective with an incremental cost-effectiveness ratio (ICER) of 13,580 (95% CI: 13,294, 13,867) US$/QALY and was the preferred option in the base case scenario. CONCLUSION: The introduction of QIVs to school children, elderly adults, or HCWs is likely to be cost-effective, either separately or collectively. The introduction of QIV to school children, elderly adults, and health care workers simultaneously showed the highest probability of being cost-effective and was the preferred option.


Assuntos
COVID-19 , Vacinas contra Influenza , Influenza Humana , Adulto , Idoso , Pequim , Criança , Análise Custo-Benefício , Humanos , Influenza Humana/prevenção & controle , Pessoa de Meia-Idade , SARS-CoV-2 , Estações do Ano
4.
Journal of Hydrology ; 603:N.PAG-N.PAG, 2021.
Artigo em Inglês | Academic Search Complete | ID: covidwho-1568844

RESUMO

• Hybrid ELM models (PSO-ELM, GA-ELM and ABC-ELM) were proposed for estimating ET 0 in different climate zones of China. • PSO-ELM model had the highest accuracy, followed by GA-ELM and ABC-ELM. • Hybrid ELM models outperformed standalone ELM and empirical models in different climate zones. • PSO-ELM model with T max , T min and RH obtained accurate ET 0 estimates in TCZ, SMZ and TMZ. • PSO-ELM model with only T max and T min was better performance on ET 0 estimates in MPZ. Accurate prediction of reference crop evapotranspiration (ET 0) is important for regional water resources management and optimal design of agricultural irrigation system. In this study, three hybrid models (PSO-ELM, GA-ELM and ABC-ELM) integrating the extreme learning machine model (ELM) with three biological heuristic algorithms, i.e., PSO, GA and ABC, were proposed for predicting daily ET 0 based on daily meteorological data from 2000 to 2019 at twelve representative stations in different climatic zones of China. The performances of the three hybrid ELM models were further compared with the standalone ELM model and three empirical models (Hargreaves, Priestley-Talor and Makkink models). The results showed that the hybrid ELM models (R 2 = 0.973–0.999) all performed better than the standalone ELM model (R 2 = 0.955–0.989) in four climatic regions in China. The estimation accuracy of the empirical models was relatively lower, with R2 of 0.822–0.887 and RMSE of 0.381–1.951 mm/d. The R 2 values of PSO-ELM, GA-ELM and ABC-ELM models were 0.993, 0.986 and 0.981 and the RMSE values were 0.266 mm/d, 0.306 mm/d and 0.404 mm/d, respectively, indicating that the PSO-ELM model had the best performance. When setting T max , T min and RH as the model inputs, the PSO-ELM model presented better performance in the temperate continental zone (TCZ), subtropical monsoon region (SMZ) and temperate monsoon zone (TMZ) climate zones, with R 2 of 0.892, 0866 and 0.870 and RMSE of 0.773 mm/d, 0.597 mm/d and 0.832 mm/d, respectively. The PSO-ELM model also performed in the mountain plateau region (MPZ) when only T max and T min data were available, with R2 of 0.808 and RMSE of 0.651 mm/d. All the three biological heuristic algorithms effectively improved the performance of the ELM model. Particularly, the PSO-ELM was recommended as a promising model realizing the high-precision estimation of daily ET 0 with fewer meteorological parameters in different climatic zones of China. [ FROM AUTHOR] Copyright of Journal of Hydrology is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full . (Copyright applies to all s.)

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA